Tezepelumab is a fully human IgG2 mAb directed to the thymic stromal lymphopoietin (Figure 1)—a cytokine of the alarmin family that, together with IL-25 and IL-33, is derived from epithelial cells and plays a very important role in the pathogenesis of asthma [55]. The gene discussed is IL33; the disease is asthma.